| Primary |
| Crohn's Disease |
44.6% |
| Colitis |
12.0% |
| Colitis Ulcerative |
8.8% |
| Colitis Microscopic |
6.6% |
| Hypertension |
3.8% |
| Diarrhoea |
3.5% |
| Colitis Collagenous |
2.7% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Autoimmune Hepatitis |
2.1% |
| Depression |
1.4% |
| Fungal Infection |
1.4% |
| Abdominal Pain |
1.3% |
| Coeliac Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Medical Diet |
1.3% |
| Sleep Disorder |
1.3% |
| Blood Pressure Abnormal |
1.1% |
| Irritable Bowel Syndrome |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Fibromyalgia |
1.0% |
|
| Drug Dose Omission |
13.6% |
| Off Label Use |
10.3% |
| Weight Decreased |
10.3% |
| Crohn's Disease |
8.9% |
| Malaise |
6.1% |
| Weight Increased |
5.1% |
| Pruritus |
4.7% |
| Colitis |
4.2% |
| Diarrhoea |
4.2% |
| Abdominal Distension |
3.7% |
| Rash |
3.7% |
| Drug Ineffective |
3.3% |
| Nausea |
3.3% |
| Osteoporosis |
3.3% |
| Cataract |
2.8% |
| Joint Swelling |
2.8% |
| Vomiting |
2.8% |
| Blood Glucose Increased |
2.3% |
| Pain |
2.3% |
| Psoriasis |
2.3% |
|
| Secondary |
| Crohn's Disease |
32.4% |
| Product Used For Unknown Indication |
13.8% |
| Colitis Ulcerative |
7.7% |
| Colitis |
7.5% |
| Colitis Microscopic |
6.7% |
| Drug Use For Unknown Indication |
3.3% |
| Depression |
3.0% |
| Diarrhoea |
3.0% |
| Hypertension |
3.0% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Arthralgia |
2.3% |
| Sleep Disorder |
2.3% |
| Blood Pressure Abnormal |
2.1% |
| Anxiety |
1.8% |
| Insomnia |
1.8% |
| Asthma |
1.5% |
| Coeliac Disease |
1.5% |
| Colitis Collagenous |
1.4% |
| Supplementation Therapy |
1.4% |
| Mineral Supplementation |
1.2% |
|
| Weight Decreased |
23.3% |
| Off Label Use |
9.2% |
| Vomiting |
8.0% |
| Pruritus |
7.4% |
| Gastrointestinal Haemorrhage |
5.5% |
| Abdominal Distension |
4.3% |
| Malaise |
3.7% |
| Nasopharyngitis |
3.7% |
| Tremor |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Weight Increased |
3.7% |
| Drug Dose Omission |
3.1% |
| Myopathy |
3.1% |
| Pain In Extremity |
3.1% |
| Diabetes Mellitus |
2.5% |
| Diarrhoea |
2.5% |
| Drug Ineffective |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Nausea |
2.5% |
| Skin Exfoliation |
2.5% |
|
| Concomitant |
| Crohn's Disease |
36.8% |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
7.8% |
| Hypertension |
2.8% |
| Pain |
2.8% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Colitis Ulcerative |
2.0% |
| Abdominal Pain |
1.9% |
| Anxiety |
1.9% |
| Depression |
1.8% |
| Nausea |
1.8% |
| Insomnia |
1.6% |
| Vitamin Supplementation |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Diarrhoea |
1.1% |
| Prophylaxis |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Anaemia |
1.0% |
| Colitis |
0.7% |
| Constipation |
0.7% |
|
| Vomiting |
12.0% |
| Injection Site Pain |
8.4% |
| Crohn's Disease |
8.2% |
| Weight Decreased |
8.0% |
| Nausea |
6.3% |
| Pyrexia |
5.9% |
| Rash |
5.7% |
| Diarrhoea |
5.0% |
| Drug Ineffective |
4.6% |
| Pain |
4.6% |
| Abdominal Pain |
4.2% |
| Small Intestinal Obstruction |
4.2% |
| Arthralgia |
3.4% |
| Intestinal Obstruction |
3.2% |
| Fatigue |
2.9% |
| Incorrect Dose Administered |
2.9% |
| Headache |
2.7% |
| Systemic Lupus Erythematosus |
2.7% |
| Insomnia |
2.5% |
| Urticaria |
2.5% |
|
| Interacting |
| Colitis Ulcerative |
26.1% |
| Gastroenteritis Eosinophilic |
21.7% |
| Antiretroviral Therapy |
17.4% |
| Crohn's Disease |
13.0% |
| Arthritis Enteropathic |
4.3% |
| Aspergillosis |
4.3% |
| Chronic Granulomatous Disease |
4.3% |
| Colitis |
4.3% |
| Menopausal Symptoms |
4.3% |
|
| Drug Interaction |
63.6% |
| Cushing's Syndrome |
9.1% |
| Malaise |
9.1% |
| Menopausal Symptoms |
9.1% |
| Sepsis |
9.1% |
|
